Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
15,663
+2,953
+23% +$78.6K 0.06% 217
2025
Q4
$316K Buy
12,710
+3,414
+37% +$86.1K 0.06% 191
2025
Q3
$237K Buy
9,296
+1
+0% +$25 0.05% 209
2025
Q2
$225K Buy
9,295
+138
+2% +$3.22K 0.05% 217
2025
Q1
$232K Sell
9,157
-2,106
-19% -$55.1K 0.07% 224
2024
Q4
$299K Sell
11,263
-5,367
-32% -$146K 0.09% 185
2024
Q3
$481K Buy
16,630
+3,722
+29% +$109K 0.18% 102
2024
Q2
$361K Buy
+12,908
New +$355K 0.19% 118

Other funds holding PFE

Seeds Investor's PFE Position: Q1 2026 in Review

Seeds Investor increased its Pfizer (PFE) stake by 23% in Q1 2026, buying an estimated $78.6K and bringing the position to 15,663 shares worth $425K. The position accounts for 0.06% of the portfolio, ranked #217.

Seeds Investor first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. The position peaked at $481K in Q3 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Seeds Investor held 15,663 shares of Pfizer worth $425K as of Q1 2026.
  • Seeds Investor bought 2,953 Pfizer shares in Q1 2026, an estimated $78.6K.
  • Pfizer made up 0.06% of Seeds Investor's portfolio in Q1 2026, its #217 holding.
  • Seeds Investor first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • Seeds Investor's Pfizer position peaked at $481K in Q3 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Seeds Investor's 13F filing for Q1 2026, filed 11 May 2026.